The World Health Organisation (WHO) has reported that cases of measles in Europe have hit a record high. Measles is a highly infectious virus that spreads via droplets in coughs and sneezes. Over 41,000 people have been infected in the first six months of 2018, and has led to 37 deaths. Last year there were
As European Union leaders prepare for Brexit negotiations with the UK, Ireland has stepped up its bid to make Dublin the new home of the EU’s medicines agency. The EMA looks relatively certain to leave its current residence in east London because of Brexit, and many EU cities are eager to be chosen as the
UK-based GW Pharmaceuticals’ cannabinoid Epidiolex has been awarded Orphan status by European regulators as treatment for Lennox-Gastaut Syndrome (LGS), a rare and severe form of childhood-onset epilepsy. The approval follows data from two late-stage trials that showed when Epidiolex was added as an adjunct to patients’ current treatment, there was a significant reduction in the
Results from a survey analysing the prescribing behaviour of 500 European physicians treating patients with advanced non-small cell lung cancer (NSCLC) have been published in Clinical Lung Cancer. The research examined the primary therapy goal of physicians and their choice of treatment for patients with advanced adenocarcinoma of the lung, after first-line chemotherapy. An overview
On Thursday June 23rd 2016, tens of millions of people within the UK voted on whether we should remain within the EU. The following day it was announced that the UK will be set to leave the EU with the votes swaying 51.9% for leave and 48.1% for remain, with a 72.2% turnout. In light
Four of the industry leading research groups in the EU have joined to launch an international project with the aim to set up a large, globally accessible, bank of new cancer cell culture models for future research. The National Cancer Institute (NCI), Cancer Research UK, the Wellcome Trust Sanger Institute and the foundation Hubrecht Organoid
The EU’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of potentially the first corrective ex vivo gene therapy for children anywhere in the world. GlaxoSmithKline received the green light from the CHMP for Strimvelis as a treatment for the rare disease ADA-SCID. Which is combined immunodeficiency due to adenosine deaminase
ACM Global Central Laboratory, the US-headquartered laboratory testing operation that raised its European profile in March 2009 by acquiring Pivotal Laboratories, have relocated their European laboratory to a bigger facility in York’s Hospital Fields Road. ACM Global confirmed that they have outgrown their prior facility in Aviator Court, York, which they have occupied since 1999.
In spite of the financial crisis, healthcare across Europe continues to improve, with consumer empowerment motivating advances in quality and access. However, the distribution of cancer drugs within the UK is still “deplorable,” states a new review, presented at the European Parliament in Brussels. The Netherlands appears first in the latest Euro Health Consumer Index
The EU Court of Justice ruled on Thursday last week that a Polish law which allows the sale of prescription medicine that has not been permitted by the European Medicines Agency (EMA) but is similar and cheaper to drugs which have, breaches European Union (EU) law. Under European law, no prescription drug can be offered
